QSARs for 6-Azasteroids as Inhibitors of Human Type 1 5α-Reductase: Prediction of Binding Affinity and Selectivity Relative to 3-BHSD

Journal of Chemical Information and Computer Sciences

Volumn 41, Issue 3-6, 2001, Pages 1255-1265

  Bakken, Gregory A ^a   Jurs, Peter C ^a  

^a PENNSYLVANIA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 BETA HYDROXYSTEROID OXIDOREDUCTASE DELTA(5) 3 KETOSTEROID ISOMERASE; 3 BETA-HYDROXYSTEROID OXIDOREDUCTASE-DELTA(5) 3-KETOSTEROID ISOMERASE; 3BETA HYDROXY DELTA5 STEROID DEHYDROGENASE; AZASTEROID; CHOLESTENONE 5ALPHA REDUCTASE; ENZYME INHIBITOR; MULTIENZYME COMPLEX; OXIDOREDUCTASE; STEROID DELTA ISOMERASE;

ARTICLE; BIOLOGICAL MODEL; CHEMISTRY; DRUG ANTAGONISM; HUMAN; IN VITRO STUDY; KINETICS; METABOLISM; MONTE CARLO METHOD; QUANTITATIVE STRUCTURE ACTIVITY RELATION; VALIDATION STUDY;

AZASTEROIDS; CHOLESTENONE 5 ALPHA-REDUCTASE; ENZYME INHIBITORS; HUMANS; KINETICS; MODELS, BIOLOGICAL; MONTE CARLO METHOD; MULTIENZYME COMPLEXES; OXIDOREDUCTASES; PROGESTERONE REDUCTASE; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP; STEROID ISOMERASES;

AZASTEROIDS;

ENZYME INHIBITION; LEAST SQUARES APPROXIMATIONS; MONTE CARLO METHODS; NEURAL NETWORKS; REGRESSION ANALYSIS; TOPOLOGY;

MOLECULAR STRUCTURE;

EID: 0035438389     PISSN: 00952338     EISSN: None     Source Type: Journal    
DOI: 10.1021/ci010036q     Document Type: Article

References (54)

1. Singh, S. M.; Gauthier, S.; Labrie, F. Androgen Receptor Antagonists (Antiandrogens): Structure-Activity Relationships. Curr. Med. Chem. 2000, 7, 211-247.
2. Clifford, G. M.; Farmer, R. D. T. Medical Therapy for Benign Prostatic Hyperplasia: A Review of the Literature. Eur. Urol. 2000, 38, 2-19.
3. Bartsch, G.; Rittmaster, R. S.; Klocker, H. Dihydrotestosterone and the Concept of 5α-Reductase Inhibition in Human Benign Prostatic Hyperplasia. Eur. Urol. 2000, 37, 367-380.
4. Weisser, H.; Tunn, S.; Debus, M.; Krieg, M. 5α-Reductse inhibition by finasteride (Proscar) in epithelium and stroma of human benign prostatic hyperplasia. Steroids 1994, 59, 616-620.
5. Tolman, R. L.; Sahoo, S. P.; Bakshi, R. K.; Gratale, D.; Patel, G.; Patel, S.; Toney, J.; Chang, B.; Harris, G. S. 4-Methyl-3-oxo-4-aza-5α-androst-1-ene-17β-N-aryl-carboxamides: an Approach to Combined Androgen Blockade [5α-Reductase Inhibition with Androgen Receptor Binding In Vitro]. J. Steroid Biochem. Mol. Biol. 1997, 60, 303-309.
6. 17α): Potential Agents for the Treatment of Prostate Cancer. J. Med. Chem. 1998, 41, 902-912.
7. 17α). J. Med. Chem. 1997, 40, 3297-3304.
8. Thiboutot, D.; Bayne, E.; Thorne, J.; Gilliland, K.; Flanagan, J.; Shao, Q.; Light, J.; Helm, K. Immunolocalization of 5α-Reductase Isozymes in Acne Lesions and Normal Skin. Arch. Dermatol. 2000, 136, 1125-1129.
9. Guarna, A.; Occhiato, E. G.; Banzo, G.; Conti, A.; Serio, M. 5α-reductase inhibitors, chemical and clinical models. Steroids 1998, 63, 355-361.
10. Guarna, A.; Machetti, F.; Occhiato, E. G.; Scarpi, D. Benzo[c]-quinolizin-3-ones: A Novel Class of Potent and Selective Nonsteroidal Inhibitors of Human Steroid 5α-Reductase 1. J. Med. Chem. 2000, 43, 3718-3735.
11. Hogan, D. J.; Chamberlain, M. Male Pattern Baldness. South. Med. J. 2000, 93, 657-662.
12. Russell, D. W.; Wilson, J. D. Steroid 5α-reductase: two genes/two enzymes. Annu. Rev. Biochem. 1994, 63, 25-61.
13. 5-steroid Isomerase by 6-Azaandrost-4-en-3-ones: Optimization of the C17 Substituent. J. Med. Chem. 1995, 38, 2621-2627.
14. 5-steroid Isomerase. J. Med. Chem. 1994, 37, 2352-2360.
15. Kurup, A.; Garg, R.; Hansch, C. Comparative QSAR Analysis of 5α-Reductase Inhibitors. Chem. Rev. 2000, 100, 909-924.
16. Rasmusson, G. H.; Reynolds, G. F.; Steinberg, N. G.; Walton, E.; Patel, G. F.; Liang, T.; Cascieri, M. A.; Cheung, A. H.; Brooks, J. R.; Berman, C. Azasteroids: Structure-Activity Relationships for Inhibition of 5α-Reductase and of Androgen Receptor Binding. J. Med. Chem. 1986, 29, 2298-2315.
17. Hartmann, R. W.; Reichert, M. New Nonsteroidal Steroid 5α-Reductase Inhibitors. Syntheses and Structure-Activity Studies on Carboxamide Phenylalkyl-Substituted Pyridones and Piperidones. Arch. Pharm. Pharm. Med. Chem. 2000, 333, 145-153.
18. Bakken, G. A.; Jurs, P. C. Prediction of Hydroxyl Radical Rate Constants from Molecular Structure. J. Chem. Inf. Comput. Sci. 1999, 39, 1064-1075.
19. Kauffman, G. W.; Jurs, P. C. Prediction of Inhibition of the Sodium Ion-Proton Antiporter by Benzoylguanidine Derivatives from Molecular Structure. J. Chem. Inf. Comput. Sci. 2000, 40, 753-761.
20. Johnson, S. R.; Jurs, P. C. Prediction of the Clearing Temperature of a Series of Liquid Crystals from Molecular Structure. Chem. Mater. 1999, 11, 1007-1023.
21. Wessel, M. D.; Jurs, P. C.; Tolan, J. W.; Muskal, S. M. Prediction of Human Intestinal Adsorption of Drug Compounds from Molecular Structure. J. Chem. Inf. Comput. Sci. 1998, 38, 726-735.
22. Stuper, A. J.; Brugger, W. E.; Jurs, P. C. Computer-Assisted Studies of Chemical Structure and Biological Function; Wiley: New York, 1979.
23. Jurs, P. C.; Chow, J. T.; Yuan, M. In Computer Assisted Drug Design; Olson, E. C., Christoffersen, R. E., Eds.; The American Chemical Society: Washington, DC, 1979.
24. Stewart, J. P. P. Mopac 6.0, Quantum Chemistry Program Exchange; Indiana University: Bloomington, IN, Program 455.
25. Stewart, J. P. P. MOPAC: A Semiempirical Molecular Orbital Program. J. Comput.-Aided Mol. Des. 1990, 4, 1-105.
26. Randic, M. On Molecular Identification Numbers. J. Chem. Inf. Comput. Sci. 1984, 4, 162-175.
27. Liu, S.; Cao, C.; Li, Z. Approach to Estimation and Prediction for Normal Boiling Point (NBP) of Alkanes Based on a Novel Molecular Distance-Edge (MDE) Vector, A. J. Chem. Inf. Comput. Sci. 1998, 38, 387-394.
28. Kier, L. B.; Hall, L. H. Molecular Connectivity in Structure-Activity Analysis; Research Studies Press, Ltd.: Hertfordshire, England, 1986.
29. Randic, M.; Brissey, G. M.; Spencer, R. B.; Wilkins, C. L. Search for All Self-Avoiding Paths for Molecular Graphs. Comput. Chem. 1979, 3, 5-13.
30. Kier, L. B. Shape Indexes of Orders One and Three from Molecular Graphs. Quant. Struct.-Act. Relat. 1986, 5, 1-7.
31. Kier, L. B.; Hall, L. H. The E-State as an Extended Free Valence. J. Chem. Inf. Comput. Sci. 1997, 37, 548-552.
32. Bondi, A. van der Waals Volumes and Radii. J. Phys. Chem. 1964, 68, 441-451.
33. Stouch, T. R.; Jurs, P. C. A Simple Method for the Representation, Quantification, and Comparison of the Volumes and Shapes of Chemical Compounds. J. Chem. Inf. Comput. Sci. 1986, 26, 4-12.
34. Miller, K. J.; Savchik, J. A. A New Empirical Method to Calculate Average Molecular Polarizabilities. J. Am. Chem. Soc. 1979, 101, 7206-7213.
35. Abraham, R. J.; Smith, P. E. Charge Calculations in Molecular Mechanics IV: A General Method for Conjugated Systems. J. Comput. Chem. 1987, 9, 288-297.
36. Dixon, S. L.; Jurs, P. C. Atomic Charge Calculations for Quantitative Structure-Property Relationships. J. Comput. Chem. 1992, 13, 492-504.
37. Stanton, D. T.; Jurs, P. C. Development and Use of Charged Partial Surface Area Descriptors in Computer-Assisted Quantitative Structure-Property Relationship Studies. Anal. Chem. 1990, 62, 2323-2329.
38. Vinogradov, S. N.; Linnell, R. H. Hydrogen Bonding; van Nostrand Reinhold: New York, 1971.
39. Pimentel, G. I.; McClellan, A. L. The Hydrogen Bond; Freeman: San Francisco, 1960.
40. Stenberg, P.; Luthman, K.; Artursson, P. Virtual screening of intestinal drug permeability. J. Contr. Relat. 2000, 65, 231-243.
41. Palm, K.; Luthman, K.; Ungell, A.-L.; Strandlund, G.; Beigi, F.; Lundahl, P.; Artursson, P. Evaluation of Dynamic Polar Molecular Surface Area as Predictor of Drug Absorption: Comparison with Other Compuational and Experimental Predictors. J. Med. Chem. 1998, 41, 5382-5392.
42. Palm, K.; Luthman. K.; Ungell, A.-L.; Strandlund, G.; Artursson, P. Correlation of Drug Absorption with Molecular Surface Properties. J. Pharm. Sci. 1996, 85, 32-39.
43. Clark, D. E. Rapid Calculation of Polar Molecular Surface Area and Its Application to the Prediction of Transport Phenomena. I. Prediction of Intestinal Absorption. J. Pharm. Sci. 1998, 88, 807-814.
44. Anton, H. Elementary Linear Algebra, 6th ed.; John Wiley & Sons: New York, 1991.
45. Kalivas, J. H.; Roberts, N.; Sutter, J. M. Global Optimization by Simulated Annealing with Wavelength Selection for Ultraviolet-Visible Spectrophotometry. Anal. Chem. 1989, 61, 2024-2030.
46. Sutter, J. M.; Dixon, S. L.; Jurs, P. C. Automated Descriptor Selection for Quantitative Structure-Activity Relationships Using Generalized Simulated Annealing. J. Chem. Inf. Comput. Sci. 1995, 35, 77-84.
47. Kalivas, J. H. Generalized Simulated Annealing for Calibration Sample Selection from an Existing Set and Orthogonalization of Undesigned Experiments. J. Chemom. 1991, 5, 37-48.
48. Belsley, D. A.; Kuh, E.; Welsch, R. E. Regression Diagnostics: Identifying Influential Data and Sources of Collinearity, John Wiley & Sons: New York, 1980.
49. Xu, L.; Ball, J. W.; Dixon, S. L.; Jurs, P. C. Quantitative Structure-Activity Relationships for Toxicity of Phenols Using Regression Analysis and Computational Neural Networks. Environ. Toxicol. Chem. 1994, 13, 841-851.
50. Wessel, M. D.; Jurs, P. C. Prediction of Reduced Ion Mobility Constants from Structural Information Using Multiple Lienar Regression Analysis and Computational Neural Networks. Anal. Chem. 1994, 66, 2480-2487.
51. Kimura, T.; Hasegawa, K.; Funatsu, K. GA Strategy for Variable Selection in QSAR Studies: GA-Based Region Selection for CoMFA Modeling. J. Chem. Inf. Comput. Sci. 1998, 38, 276-282.
52. Luke, B. T. Evolutionary Programming Applied to the Development of Quantitative Structure-Property Relationships. J. Chem. Inf. Comput. Sci. 1994, 34, 1279-1287.
53. Kalivas, J. H.; Lang, P. M. Mathematical Analysis of Spectral Orthogonality; Marcel Dekker: New York, 1993.
54. Malinowski, E. R. Factor Analysis in Chemistry, 2nd ed.; John Wiley & Sons: New York, 1991.